Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -1.068M
March 31, 2026 -16.30M
December 31, 2025 -2.551M
September 30, 2025 -6.78M
June 30, 2025 -1.62M
March 31, 2025 -1.353M
December 31, 2024 -0.5962M
September 30, 2024 -1.351M
June 30, 2024 -9.381M
March 31, 2024 -1.611M
December 31, 2023 11.95M
September 30, 2023 -1.502M
June 30, 2023 -2.32M
March 31, 2023 -0.701M
December 31, 2022 -1.019M
September 30, 2022 -0.838M
June 30, 2022 -11.85M
March 31, 2022 -0.518M
December 31, 2021 -1.581M
September 30, 2021 -1.441M
June 30, 2021 -1.871M
March 31, 2021 -1.48M
December 31, 2020 -9.797M
September 30, 2020 -0.758M
June 30, 2020 -0.726M
Date Value
March 31, 2020 -2.671M
December 31, 2019 -0.5575M
September 30, 2019 -0.364M
June 30, 2019 -0.321M
March 31, 2019 -0.438M
December 31, 2018 -0.9789M
September 30, 2018 -0.433M
June 30, 2018 -0.922M
March 31, 2018 -0.897M
December 31, 2017 -4.745M
September 30, 2017 -0.801M
June 30, 2017 -1.096M
March 31, 2017 -7.737M
December 31, 2016 -0.4901M
September 30, 2016 -0.568M
June 30, 2016 -0.322M
March 31, 2016 -7.43M
December 31, 2015 -0.5146M
September 30, 2015 -0.529M
June 30, 2015 -0.296M
March 31, 2015 -0.574M
December 31, 2014 -0.6224M
September 30, 2014 -0.453M
June 30, 2014 -13.33M
March 31, 2014 -0.79M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Cencora, Inc. -240.15M
Abbott Laboratories -673.00M
Align Technology, Inc. -82.16M
AngioDynamics, Inc. -1.27M
Accuray, Inc. -1.353M